Clinical Trial Update: Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. [Phase 2]

View source ↗

Summary

The Phase 2 multicenter trial evaluating imatinib (Glivec) in patients with tumors positive for C-kit or PDGFR and with metastatic solid tumors has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Glivec (imatinib)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Metastatic Solid Tumors. | Phase 2 | Status: WITHDRAWN